Human case of bird flu recorded in the UK as prevention zone launched
A case of a human with brid flu has been recorded in the West Midlands.
The local resident has contracted bird flu after prolonged contact with infected birds, the UK Health Security Agency (UKHSA) has confirmed.
This marks a rare occurrence, with only seven cases identified in the UK since 2021. The UKHSA has stressed that the risk to the general public remains 'very low.'
The individual, who displayed symptoms but is now recovering, is receiving care in a High Consequence Infectious Disease (HCID) unit, a standard procedure for such cases. The infection was traced to a farm where birds carried the DI.2 genotype of the virus, a strain currently circulating among avian populations in the UK. Importantly, this differs from the strains affecting mammals and birds in the US.
The case was detected through routine bird flu surveillance. As a precautionary measure, anyone who had contact with the infected individual, particularly those at higher risk of exposure, has been offered antiviral treatment.
Symptoms of Avian Flu in humans
The Nhs says the main symptoms of bird flu can appear very quickly and include:
a very high temperature or feeling hot or shivery
aching muscles
headache
a cough or shortness of breath
Other early symptoms may include:
diarrhoea
sickness
stomach pain
chest pain
bleeding from the nose and gums
conjunctivitis
It usually takes 3 to 5 days for the first symptoms to appear after you've been infected.
Within days of symptoms appearing, it's possible to develop more severe complications such as pneumonia and acute respiratory distress syndrome.
Prevention zone
A national Avian Influenza Prevention Zone (AIPZ) came into force for the whole of England and Scotland at noon on Saturday in a bid to mitigate the risk of the disease spreading amongst poultry and other captive birds.
It is now a legal requirement for all bird keepers in Scotland and England to follow strict rules to protect their flocks from the threat of avian flu – including keeping birds indoors.
Professor Susan Hopkins, chief medical adviser at UKHSA, said: 'The risk of avian flu to the general public remains very low despite this confirmed case.
'We have robust systems in place to detect cases early and take necessary action, as we know that spillover infections from birds to humans may occur.
'Currently there is no evidence of onwards transmission from this case.
'People are reminded not to touch sick or dead birds and it's important that they follow Defra advice about reporting any suspected avian influenza cases.'
How bird flu spreads to humans
Human-to-human transmission of bird flu has never been documented in Europe or the UK, though has occasionally happened abroad.
Bird flu is spread by close contact with an infected bird (dead or alive).
This includes touching infected birds, touching droppings or bedding, killing or preparing infected poultry for cooking
Markets where live birds are sold can also be a source of bird flu. Avoid visiting these markets if you're travelling to countries that have had an outbreak of bird flu. You can check health advice for the country you're visiting on the TravelHealthPro website.
You can't catch bird flu through eating fully cooked poultry or eggs, even in areas with an outbreak of bird flu.
Health minister Andrew Gwynne, said the safety of the public is paramount.
'The risk of wider or onward transmission is very low, however the UK remains prepared and ready to respond to any current and future health threats,' he added.
'We recently added the H5 vaccine, which protects against avian influenza, to our stockpile as part of our preparedness plans.'
The UK outbreak comes as The US is dealing with the results of an epidemic in 2022.
UK chief veterinary officer, Christine Middlemiss, said: 'While avian influenza is highly contagious in birds, this is a very rare event and is very specific to the circumstances on this premises.
'We took swift action to limit the spread of the disease at the site in question, all infected birds are being humanely culled, and cleansing and disinfection of the premises will be undertaken all to strict biosecure standards.
'This is a reminder that stringent biosecurity is essential when keeping animals.
'We are seeing a growing number of avian flu cases in birds on both commercial farms and in backyard flocks across the country.
'Implementing scrupulous biosecurity measures will help protect the health and welfare of your birds from the threat of avian influenza and other diseases.'
Professor Jonathan Ball, from the Liverpool School of Tropical Medicine (LSTM), said: 'Even in the rare cases where people do become infected, onward human to human transmission is very unlikely.
'However, that doesn't mean we can be complacent.
'There is always the risk that the virus can evolve and become better adapted to spread amongst humans, so it's important to be vigilant, to ensure good wild fowl and poultry surveillance and when human cases do occur, to isolate the patient to remove the risk of onward transmission.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Telegraph
2 hours ago
- Telegraph
NHS faces paying more for US drugs to avoid future Trump tariffs
Britain faces paying more for US drugs as part of a deal to avoid future tariffs from Donald Trump. The NHS will review drug pricing to take into account the 'concerns of the president', according to documents released after a trade agreement was signed earlier this year. White House sources said it expected the NHS to pay higher prices for American drugs in an attempt to boost the interests of corporate America. A Westminster source said: 'There's an understanding that we would look at the drug pricing issue in the concerns of the president.' The disclosure is likely to increase concerns about American interference in the British health service, which has long been regarded as a flashpoint in trade talks. It comes after Rachel Reeves announced a record £29 billion investment in the NHS in last week's spending review. The Chancellor's plans will drive spending on the health service up towards 50 per cent of all taxpayer expenditure by the mid-2030s, according to economists at the Resolution Foundation. The Telegraph has also learnt that under the terms of the trade deal with America, the UK has agreed to take fewer Chinese drugs, in a clause similar to the 'veto' given to Mr Trump over Chinese investment in Britain. The White House has asked the UK for assurances that steel and pharmaceutical products exported to the US do not originate in China, amid fears the deal could be used to 'circumvent' Mr Trump's punishing tariffs on Beijing. Mr Trump is enraged by how much more America pays for drugs compared with other countries and considers it to be the same issue as he has raised on defence spending. Just as the US president has heaped pressure on European nations to increase the GDP share they allocate to defence, he thinks they should spend more on drug development. An industry source said: 'The way we've been thinking about it and many in the administration have been thinking about it, it's more like the model in Nato, where countries contribute some share of their GDP.' Britain and the US 'intend to promptly negotiate significantly preferential treatment outcomes on pharmaceuticals and pharmaceutical ingredients', the trade deal reads. Pharmaceutical companies are also pushing for reductions in the revenue sales rebates they pay to the NHS under the voluntary scheme for branded medicines pricing, access and growth (VPAG) – a mechanism that the UK uses to make sure the NHS does not overpay. Non-US countries are 'free-riding' Last week, Albert Bourla, Pfizer's chief executive, said non-US countries were 'free-riding' and called for a US government-led push to make other nations increase their proportionate spend on innovative medicines. He said White House officials were discussing drug prices in trade negotiations with other countries. 'We represent in UK 0.3pc of their GDP per capita. That's how much they spend on medicine. So yes, they can increase prices,' Mr Bourla said. Industry sources said there was no indication yet on what the White House would consider to be a fair level of spending. Whatever the benchmark, Britain will face one of the biggest step-ups. UK expenditure on new innovative medicines is just 0.28pc of its GDP, roughly a third of America's proportionate spending of 0.78pc of its GDP. Even among other G7 nations, the UK is an anomaly. Germany spends 0.4pc of its GDP while Italy spends 0.5pc. Most large pharmaceutical companies generate between half and three quarters of their profits in the US, despite the fact that America typically makes up less than a fifth of their sales. This is because drug prices outside of the US can cost as little as 30pc of what Americans pay. Yet, pharmaceutical companies rely on higher US prices to fund drug research and development, which the rest of the world benefits from. A month ago, Mr Trump signed an executive order titled 'Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients', which hit out at 'global freeloading' on drug pricing. It stated that 'Americans should not be forced to subsidise low-cost prescription drugs and biologics in other developed countries, and face overcharges for the same products in the United States' and ordered his commerce secretary to 'consider all necessary action regarding the export of pharmaceutical drugs or precursor material that may be fuelling the global price discrimination'. Trung Huynh, the head of pharma analysis at UBS, said: 'The crux of this issue is Trump thinks that the US is subsidising the rest of the world with drug prices. 'The president has said he wants to equalise pricing between the US and ex-US. And the way he wants to do it is not necessarily to bring down US prices all the way to where ex-US prices are, but he wants to use trade and tariffs as a pressure point to get countries to increase their prices. 'If he can offset some of the price by increasing prices higher ex-US, then the prices in America don't have to go down so much.' Mr Huynh added: 'It's going to be very hard for him to do. Because [in the UK deal] it hinges on the NHS, which we know has got zero money.' Under VPAG, pharmaceutical companies hand back at least 23pc of their revenue from sales of branded medicines back to the NHS, worth £3bn in the past financial year. The industry is pushing for this clawback to be cut to 10pc, which would mean the NHS would have to spend around 1.54bn more on the same medicines on an annual basis. The Government has already committed to reviewing the scheme, a decision which is understood to pre-date US trade negotiations. A government spokesman said: 'This Government is clear that we will only ever sign trade agreements that align with the UK's national interests and to suggest otherwise would be misleading. 'The UK has well-established and effective mechanisms for managing the costs of medicines and has clear processes in place to mitigate risks to supply.'
Daily Mail
3 hours ago
- Daily Mail
Lucy Letby supporter claims neo-natal unit where baby serial killer worked was 'not fit for purpose'
The Countess of Chester Hospital's neo-natal unit was 'not fit for purpose' before Lucy Letby started murdering babies, a former nurse who worked there has claimed. Michele Worden said redundancies led to a loss of senior staff and plumbing issues created a 'perfect storm' for care failings. The former advanced nurse practitioner left the Countess after being made redundant in 2007, four years before Letby started working and eight years before her killing spree began. She told the Nursing Times that when the unit was downgraded in around 2006 and stopped caring for very premature babies under 27 weeks, senior nurses were replaced with junior staff who were asked to care for infants 'above their capabilities [and] training.' She said: 'It wasn't just the neonatal unit that wasn't fit for purpose, the whole maternity and paediatric and gynaecology… was not fit for purpose. 'The problems with the sewage and blocked sinks were not just [on] the neonatal unit, it was on the labour ward, it was all over.' Ms Worden said she believed the situation at the Countess of Chester was 'no different' to other NHS hospitals where maternity scandals have been uncovered in recent years. 'Hopefully Lucy will be exonerated,' she said. 'Chester is no different than Shrewsbury, Nottingham, Morecambe Bay. Women and children's healthcare has never been a high priority.' Letby, 38, is serving 15 whole life terms after being convicted of the murder of seven babies and attempted murder of seven more, including one baby girl she tried to kill twice. Plumber Lorenzo Mansutti, estates manager at the Countess, was the only witness called by Letby in her defence at her Manchester Crown Court trial. He admitted drainage problems were a 'weekly' issue at the hospital's 50-year-old Women's and Children's Building and told the jury that he remembered an incident when raw sewage backed up into sinks in the intensive care nursery. But he said it was a 'one off' and insisted that at no point were staff unable to wash their hands because the hospital had 'backup' portable handwashing units on site. The problem was not logged as a formal incident, so no exact date for the incident could be found. Letby's trial heard that none of the seven babies who died collapsed due to a bacterial infection associated with poor sewage. Cheshire police are continuing to investigate the former nurse and last year confirmed they had questioned her in prison in connection with more baby deaths. But, following a presentation from 14 international experts in February, who claim none of the babies were murdered but died due to poor care, there has been a continued chorus of people questioning the safety of her convictions. Letby has twice applied and been refused leave to appeal, but her new legal team have submitted a file of evidence to the Criminal Cases Review Commission, the body that investigates potential miscarriages of justice, in a last ditch attempt to get her convictions overturned. They claim the testimony of lead prosecution expert Dewi Evans was biased and that he changed his mind over the method of murder of one of the children murdered by Letby, a boy known as Baby C. Dr Evans has denied this and the Court of Appeal has already dismissed claims he was not suitably qualified or lacked independence. Yesterday it emerged that Dr Evans, who has been subjected to intense trolling online from Letby supporters, had been involved in an online row with one of them - an anonymous statistician who Dr Evans accused of being motivated by a sexual attraction to Letby. According to the statistician, Dr Evans wrote: 'You seem very intense, and it's not unusual for men to have the hots for pretty young blonde females. A nursing uniform is a turn-on for some by all accounts. 'I would suggest you need to get out more, find yourself an available pretty young blonde female, with/without nursing credentials. But one who doesn't go to work intent on murdering her patients.' The statistician said it was 'absurd' to say he believed Letby was innocent because she was 'blonde and pretty' and insisted he had come to that view after reviewing the transcripts of the trial.
BBC News
4 hours ago
- BBC News
Completion of £16m Trowbridge medical centre 'firmly in sight'
The completion of a £16m integrated care centre is "firmly in sight" following the installation of a new roof. The Trowbridge Integrated Care Centre in Wiltshire has been described as a "state-of-the-art health and care facility" and is due to open to patients early next site will become the location for the minor injury unit and X-ray department that are currently based within the nearby Trowbridge Community executive lead for cancer, planned care and community, Caroline Holmes, said: "The building work is well under way, the finish line is firmly in sight, and local people can now see their new integrated care centre really begin to take shape. Using the latest green technology, such as solar panels and heat pumps, the centre is designed to be fully self-sufficient and net zero carbon. Representatives from Bath and North East Somerset, Swindon and Wiltshire Integrated Care Board (ICB) marked the "milestone" occasion on the recently installed were joined by the Mayor of Trowbridge, along with a number of NHS colleagues who will soon call the new centre Holmes thanked those who had helped bring the new centre to added: "When the very first spades went in the ground, it was difficult to picture how a brand new health and care facility could emerge from what was essentially a very muddy field. Yet, here we are."The new centre is set to be a "flagship location" for local health and care, with teams from many different organisations, including HCRG Care Group, Avon and Wiltshire Mental Health Partnership and the Royal United Hospital, working together under one roof.
